<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Primary <z:hpo ids='HP_0003613'>Antiphospholipid Antibody</z:hpo> Syndrome (PAAS) is characterized by detection of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> associated with venous or <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> and/or <z:e sem="disease" ids="C0000786" disease_type="Disease or Syndrome" abbrv="">miscarriages</z:e> by patients with no other associated disease such as <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) </plain></SENT>
<SENT sid="1" pm="."><plain>Primary <z:hpo ids='HP_0003613'>Antiphospholipid Antibody</z:hpo> Syndrome has many clinical manifestations of which dermatological ones are probably the most common </plain></SENT>
<SENT sid="2" pm="."><plain>The purpose of this study was to determine the frequency of each cutaneous lesion, describing clinical features essential for diagnosis, in patients with <z:hpo ids='HP_0003613'>Antiphospholipid Antibody</z:hpo> Syndrome (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AAS</z:e>) attending Walter Cant√≠dio University Hospital </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Sixty patients with clinical findings suggestive of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AAS</z:e> were screened, and submitted for clinical and laboratory evaluations including <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (KCT), anticardiolipin antibodies (IgG and IgM: ELISA), routine laboratory tests and screening tests for possible associated conditions </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Twenty-five cases of primary and 14 cases of secondary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AAS</z:e> were diagnosed by clinical and laboratory evidences </plain></SENT>
<SENT sid="5" pm="."><plain>Persistent elevated <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> without history of <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> or <z:e sem="disease" ids="C0000786" disease_type="Disease or Syndrome" abbrv="">miscarriages</z:e> were demonstrated in 21 patients </plain></SENT>
<SENT sid="6" pm="."><plain>Forty percent of the patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AAS</z:e> had a cutaneous feature as the major complaint </plain></SENT>
<SENT sid="7" pm="."><plain>These were <z:e sem="disease" ids="C0343065" disease_type="Disease or Syndrome" abbrv="">dermographism</z:e> (15), <z:hpo ids='HP_0001063'>acrocyanosis</z:hpo> (13), <z:hpo ids='HP_0001025'>urticaria</z:hpo> (9), diffuse <z:hpo ids='HP_0001596'>alopecia</z:hpo> (9), <z:hpo ids='HP_0000965'>livedo reticularis</z:hpo> (seven), <z:e sem="disease" ids="C0034735" disease_type="Disease or Syndrome" abbrv="">Raynaud's phenomenon</z:e> (three), <z:hpo ids='HP_0000979'>purpura</z:hpo> (two), <z:mpath ids='MPATH_579'>ulcers</z:mpath> and <z:mp ids='MP_0001651'>necrosis</z:mp> (four), nodules (four), pterygium ungueum (one) and subungual <z:mp ids='MP_0001914'>hemorrhage</z:mp> (one) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Dermatological complaints are very frequent in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AAS</z:e> and may be the first clue to the syndrome </plain></SENT>
<SENT sid="9" pm="."><plain>Therefore a careful history and detailed physical examination are essential to diagnose <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AAS</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> dermatologists should investigate the possibility of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AAS</z:e> when facing cutaneous findings related to venous or <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> or microthrombosis </plain></SENT>
</text></document>